Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids
Phase 2
Completed
- Conditions
- Internal Hemorrhoids
- Interventions
- Drug: Placebo (Vehicle) Suppository (Nivagen)
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Nivagen Pharmaceuticals Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT03335774
- Locations
- 🇮🇳
Clinical Research, Navi Mumbai, Maharashtra, India
© Copyright 2025. All Rights Reserved by MedPath